Cellosaurus logo
expasy logo

Cellosaurus HOVTAX2-paclitaxel resistant (CVCL_AV60)

[Text version]
Cell line name HOVTAX2-paclitaxel resistant
Accession CVCL_AV60
Resource Identification Initiative To cite this cell line use: HOVTAX2-paclitaxel resistant (RRID:CVCL_AV60)
Comments Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
Miscellaneous: This cell line was orginally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
Disease Primary peritoneal serous papillary adenocarcinoma (NCIt: C7695)
Primary peritoneal carcinoma (ORDO: Orphanet_168829)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_AV53 (HOVTAX2)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=22115851; DOI=10.1016/j.ygyno.2011.11.019; PMCID=PMC3468155
Vishnu P., Colon-Otero G., Kennedy G.T., Marlow L.A., Kennedy W.P., Wu K.J., Santoso J.T., Copland J.A. 3rd
RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.
Gynecol. Oncol. 124:589-597(2012)

Cross-references
Encyclopedic resources Wikidata; Q54890192
Entry history
Entry creation02-May-2016
Last entry update19-Dec-2024
Version number8